Duchenne Muscular Dystrophy (DMD)

Eteplirsen Led to Dystrophin Production in US DMD Trial

Editor's note: This story was updated on April 27, 2012, and revised April 3, 2012.

MDA 2012 Conference Report: Genetics and Immunology Update

More than 500 physicians, allied health care professionals and MDA staff attended the MDA's 2012 Clinical Conference in Las Vegas, March 4-7.

The program emphasized:

Efficient System Developed for DMD Newborn Screening

Update 5/21/12: A podcast on this topic is now available; see Podcast Explores Newborn Screening for DMD.

Self-Portrait - Christian Reynolds

Christian created this artwork at age 10 at an MDA-sponsored children's art workshop held June 6, 1992 in Houston.  He always enjoyed swimming and fishing and going to MDA summer camp.  Christian was interested in oceanliners and maritime history and went on 10 cruises.

Self-Portrait - Julian Dombrowski

Julian created this self-portrait at age 10 at an MDA-sponsored children's art workshop held Oct. 2, 1992, at the Tucson Museum of Art.  He is a former MDA goodwill ambassador for Southern Arizona.

MDA Genetic Counseling Webinar Answers Key Questions

Respondents to MDA’s Transitions Survey — in other words, people with a neuromuscular disease who are in their teens through late 30s — made it clear they had questions about the genetics of their disease, as well as questions about family planning and the value of diagnostic testing.

MDA’s Genetic Counseling Webinar, which occurred Feb. 22, 2012, answers many of those questions.

DMD: Eteplirsen Allows Production of Functional Dystrophin

Shortened versions of the muscle protein dystrophin— produced by skipping a section of genetic instructions called exon 51— appear to be functional, says a new report from the United Kingdom.

Dhruv Prasad


Dublin, OH
Full name: 
Mr. Dhruv Prasad
Dhruv Prasad
Duchenne Muscular Dystrophy (DMD)

DMD/BMD - Nadine Wiper-Bergeron, Ph.D.

MDA awarded a research grant totaling $312,422 over a period of three years to Nadine Wiper-Bergeron, assistant professor in the department of cellular and molecular medicine at the University of Ottowa in Ontario, Canada.

MDA Commits $12 Million to Neuromuscular Disease Research

The Muscular Dystrophy Association has awarded 38 new grants totaling more than $12 million to fund research projects focused on its continuing mission to uncover the causes of, and develop therapies for, the more than 40 neuromuscular diseases in its program.

MDA's Board of Directors reviewed and approved the new grants based on recommendations from the Association's Scientific and Medical Advisory Committees, and the grants took effect Feb. 1.